参考来源:[1].Airsupra(PT027)approved in the US for asthma from https://www.astrazeneca.com/media-centre/press-releases/2023/airsupra-pt027-approved-in-the-us-for-asthma.html [2].Albuterol–Budesonide Fixed-Dose Combination Resc...
参考资料:[1].Airsupra(PT027)approved in the US for asthma from https://www.astrazeneca.com/media-centre/press-releases/2023/airsupra-pt027-approved-in-the-us-for-asthma.html [2].Albuterol–Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma from https://www.nejm.org/doi/10.1056/NE...
参考资料:[1].Airsupra(PT027)approved in the US for asthma from https://www.astrazeneca.com/media-centre/press-releases/2023/airsupra-pt027-approved-in-the-us-for-asthma.html [2].Albuterol–Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma from https://www.nejm.org/doi/10.1056/NE...
AIRSUPRA combines 2 medicines to be used as needed as a rescue inhaler in people 18 years of age and older to: treat or prevent symptoms of asthma help prevent sudden severe breathing problems (asthma attacks or exacerbations) Please see...
Airsupra is a first-in-class, pressurized metered-dose inhaler (pMDI), fixed-dose combination rescue medication containing albuterol, a short-acting beta2-agonist (SABA), and budesonide, an anti-inflammatory inhaled corticosteroid (ICS) in the US. It is being developed by AstraZeneca a...
[2].Albuterol–Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma from https://www.nejm.org/doi/10.1056/NEJMoa2203163 版权/免责说明: